ClinVar Miner

Submissions for variant NM_001013838.3(CARMIL2):c.926T>C (p.Leu309Pro)

gnomAD frequency: 0.00001  dbSNP: rs758192470
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Molecular Genetics, Royal Melbourne Hospital RCV002221414 SCV002498679 uncertain significance Severe combined immunodeficiency due to CARMIL2 deficiency 2021-08-10 criteria provided, single submitter clinical testing This sequence change is predicted to replace leucine with proline at codon 309 of the CARMIL2 protein (p.(Leu309Pro)). The leucine residue is moderately conserved (100 vertebrates, UCSC), and is located in the leucine rich LRR 5 repeat. There is a moderate physicochemical difference between leucine and proline. The variant is present in a large population cohort at a frequency of 0.0009% (2/213,250 alleles, 0 homozygotes in gnomAD v2.1). It has been identified with a likely pathogenic variant (phase unknown) in an individual with chronic warts and skin infections since childhood (Royal Melbourne Hospital). Multiple lines of computational evidence have conflicting predictions for the missense substitution (3/6 algorithms deleterious). Based on the classification scheme RMH Modified ACMG Guidelines v1.4.0, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2_Supporting, PM3_Supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.